Alpha Cognition Return on Investment 2020-2024 | ACOG

Current and historical return on investment (ROI) values for Alpha Cognition (ACOG) over the last 10 years.
Alpha Cognition ROI - Return on Investment Historical Data
Date TTM Net Income LT Investments & Debt Return on Investment
2024-06-30 $-0.01B $0.00B inf%
2024-03-31 $-0.01B -4800.00%
2023-12-31 $-0.01B -1333.33%
2023-09-30 $-0.01B -1466.67%
2023-06-30 $-0.01B $0.00B -1466.67%
2023-03-31 $-0.01B $0.00B -2400.00%
2022-12-31 $-0.01B inf%
2022-09-30 $-0.01B inf%
2022-06-30 $-0.01B -2800.00%
2022-03-31 $-0.01B -2400.00%
2021-12-31 $-0.01B -2200.00%
2021-09-30 $-0.01B $0.00B -720.00%
2021-06-30 $-0.01B $0.00B -1066.67%
2021-03-31 $-0.01B $0.00B -1066.67%
2020-12-31 $-0.01B $0.00B -933.33%
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.035B $0.000B
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
Stock Name Country Market Cap PE Ratio
Primo Water (PRMB) United States $4.535B 35.81
P.A.M Transportation Services (PAMT) United States $0.430B 0.00
Rigetti Computing (RGTI) United States $0.325B 0.00
BioHarvest Sciences (BHST) Canada $0.098B 0.00
Atlantic Coastal Acquisition II (ABP) United States $0.000B 0.00